Gene expression analyses in the primary pancreatic tumor, as well as metastatic liver lesions, have identified IGFBP1, SERPINA1, and WT1 as clinically useful biomarkers for prognostic and therapeutic purposes in metastatic pancreatic cancer [93]. This evidence concerns the gene IGFBP1 and pancreatic neoplasm.